Knowledge Distillery

The goal of this work was to evaluate whether patients with epilepsy were more susceptible to COVID-19 infection and at greater risk of severe…

With the progression of Coronavirus infectious disease-19 (COVID-19), various neurological manifestations have been noticed in these patients and…

Headache is a frequent symptom of COVID-19, and understanding its management is important for health-care professionals involved in treating the…

Fatigue in its many forms of physical, mental, and psychosocial exhaustion is a common symptom of post-COVID-19 condition, also known as “Long COVID”.

60 hospitalized patients with COVID-19 and acute neurological symptoms, 25 (42%) of them with encephalopathy and 14 (23%) with encephalitis, were…

COVID-19 pandemic caused relevant psychological consequences in the general population. Since people with Multiple Sclerosis (pwMS) are usually at…

Little is known about trajectories of recovery 12-months after hospitalisation for severe COVID. In this article the authors conducted a prospective,…

The objective of this multi-center, retrospective, cohort study was to estimate the time to recovery of command-following and associations between…

Alzheimer’s disease (AD) and COVID-19 share common risk factors including hypertension. Angiotensin converting enzyme inhibitors (ACEI) and…

Data from the early pandemic revealed that 0.62% of children hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an…

The authors compared mortality rates in 2020 (March-December) with rates in 2019 for the same period among 53 640 888 Medicare enrollees >…

To determine the impact of MS disease-modifying therapies (DMTs) on the development of cellular and humoral immunity to SARS-CoV-2 infection.